Cannabis Research
Stay abreast of cutting-edge cannabis research. Dive into studies, understand the science behind terpenes, CBD, and THC, and contribute to an informed dialogue.
497 topics in this forum
-
- 4 replies
- 1.1k views
Pot smoking could stop Mad Cow Disease? 7 December 2008 http://chattahbox.com/curiosity/2008/12/06...ad-cow-disease/ A NEW Zealand pro-cannabis group believes it has scientific evidence that cannabis can stop the development of mad cow disease the New Zealand Press Association reported today. The National Organization for the Reform of Marijuana Laws (Norml) sited a French study showing cannabidiol might be effective in preventing bovine spongiform encephalopathy (BSE), also known as mad cow disease. Scientists at the National Center for Scientific Research in France found cannabidiol - a non-psychoactive ingredient, may prevent the development of prion diseases (prog…
Last reply by TheTreeBoundRat, -
- 0 replies
- 801 views
West Coast Doctors Square Off Over PTSD Therapy Tim King Salem-News.com Salem News http://www.salem-news.com/articles/novembe...cs_11-12-08.php A combat veteran-turned-physician who treated PTSD victims for years, trades verbal blows with the psychologist pioneering virtual reality therapy for PTSD. American soldiers patrol a village in Iraq. Soldiers and Marines are increasingly developing PTSD from exposure to combat, and two experts strongly disagree over treatment methods involving virtual reality therapy. Photo by Tim King Salem-News.com (SALEM, Ore.) - Two west coast doctors, a psychiatrist and a retired osteopath, are lobbing shots at one another over how to…
Last reply by grace, -
- 0 replies
- 713 views
New Painkilling Chemical Pathway Discovery could lead to new pain treatments 26 Nov 2008 - Marijuana kills pain by activating a set of proteins known as cannabinoid receptors, which can also regulate appetite, inflammation, and memory. The body also has chemicals known as endocannabinoids that naturally activate these same receptors, namely N-arachidonoyl ethanolamine (AEA) and 2-arachidonoylglycerol (2-AG). These natural components of the cannabinoid system remain the focus of intense efforts to develop new treatments not only for chronic pain, but also for obesity, anxiety, and depression. However, until the new paper, specific methods to study 2-AG signaling have bee…
Last reply by Dragonfan, -
- 1 reply
- 850 views
'Eli Stone' wrongly paints pot as potential cure for multiple sclerosis The show also errs in its portrayal of one type of the disease as disabling and likely fatal. Marc Siegel December 1, 2008 Los Angeles Times http://www.latimes.com/features/health/la-...,5721240.column "The Humanitarian" episode, ABC, Nov. 18 The premise: Attorney Eli Stone (Jonny Lee Miller) has a rich client, Jim Cooper, whose teenage son J.J. has an illness the show characterizes as multiple sclerosis. J.J.'s supposed multiple sclerosis manifested itself with an attack when he was a young teen. The attack lasted several weeks, during which he couldn't feel anything in his arms. Since then,…
Last reply by Rocker, -
- 1 reply
- 907 views
Clinical Studies and Case Reports On this site you will find clinical studies with cannabis or single cannabinoids in different diseases and case reports on the use of cannabis by patients. You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria. http://www.cannabis-med.org/images/logo_frame.jpg
-
-
- 420 Crew
- 3 replies
- 1.4k views
Tampa Bay Online Sanofi-Aventis, Pfizer End Studies on Diet Drugs LINDA A. JOHNSON, AP Business Writer, TRENTON, N.J. French drugmaker Sanofi-Aventis said Wednesday it is halting all research on a diet drug sold in Europe, Acomplia, and rival Pfizer Inc. hours later said it is ending research on an experimental weight-loss drug in the same class. Both drugs work by blocking the pleasure centers that give marijuana smokers the "munchies" - the cannabinoid type 1, or CB1, receptors. Given that obesity and related complications are arguably the world's biggest public health problem, the demise of both drugs will be a big disappointment for patients and doctors, and possibl…
-
-
- 0 replies
- 969 views
High Expectations Research into medicinal marijuana grows up. By Amanda Schaffer Posted Thursday, Nov. 6, 2008 Slate.com http://www.slate.com/id/2203922/ This summer, British and Italian researchers found that in a laboratory plate, molecules in marijuana can slay the superbug methicillin-resistant staphylococcus aureus, which recently infected seven babies and four employees in a Yonkers, N.Y., maternity ward, heightening fears of outbreaks in schools and locker rooms, as well as in its more familiar breeding grounds, hospitals and nursing homes. In theory, compounds derived from the cannabis plant could someday serve in topical creams for patients with MRSA or other a…
Last reply by grace, -
-
- 420 Crew
- 1 reply
- 1k views
Cannabis use by people with severe mental illness – is it important? Zerrin Atakan Advances in Psychiatric Treatment (2008) 14: 423-431. doi: 10.1192/apt.bp.105.002006 © 2008 The Royal College of Psychiatrists http://apt.rcpsych.org/cgi/content/abstract/14/6/423 Zerrin Atakan worked as the lead consultant in the National Psychosis Unit at the Maudsley & Bethlem Royal Hospitals in London until August 2007, when she retired from NHS duties. She currently holds an honorary contract at the Institute of Psychiatry (De Crespigny Park, London SE5 8AF, UK; email: Zerrin.Atakan@iop.kcl.ac.uk), where she is doing research on the effects of cannabis compounds on brain functio…
Last reply by Frazz, -
-
- 1 reply
- 854 views
New Report Analyses the Market for Cannabinoid Products Live-PR Public Relations and News 31 October 2008 http://www.live-pr.com/en/new-report-analy...r1048214933.htm Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing a critical examination of current cannabinoid products and areas of unmet clinical need where the use of cannabinoids could be clinically beneficial and commercially profitable. (live-PR.com) - “Emerging Opportunities with Cannabinoids” which is available at www.piribo.com/search/results.html?k=ESP1105 reports that the psychotropic effects of Cannabis have been known for…
Last reply by Dragonfan, -
- 0 replies
- 789 views
Effects of cannabis use on outcomes of psychotic disorders: systematic review (Abstract) The British Journal of Psychiatry (2008) 193: 357-363. doi: 10.1192/bjp.bp.107.046375 © 2008 The Royal College of Psychiatrists http://bjp.rcpsych.org/cgi/content/abstract/193/5/357 Stanley Zammit, PhD Academic Unit of Psychiatry, University of Bristol, and Department of Psychological Medicine, Cardiff University Theresa H. M. Moore, MSc, BSc and Anne Lingford-Hughes, BM, BCh, PhD [/b] Academic Unit of Psychiatry, University of Bristol Thomas R. E. Barnes, MD, DSc Department of Psychological Medicine, Imperial College London Peter B. Jones, MD, PhD Department of Ps…
Last reply by grace, -
- 0 replies
- 926 views
Risk factors and outcome in psychosis Sukhwinder S. Shergill The British Journal of Psychiatry (2008) 193: A18. doi: 10.1192/bjp.193.5.A18 © 2008 The Royal College of Psychiatrists http://bjp.rcpsych.org/cgi/content/full/193/5/A18 The population prevalence of intellectual disability (also known as learning disability in UK health services) is approximately 1%, rather similar to the estimate of lifetime population risk for schizophrenia. The risk of psychiatric illness, particularly schizophrenia, is thought to be increased in people with intellectual disability. Morgan et al (pp. 364–372) linked two large population-based case registers in Australia to examine the over…
Last reply by grace, -
-
- 420 Crew
- 25 replies
- 4.3k views
Dynamic Alert Negotiates With Medical Cannabis Research & Development Firm and Appoints Former CEO of NORML, Richard Cowan as Director & CEO Sept. 19, 2008 The Wall Street Journal - Market Watch http://www.marketwatch.com/news/story/dyna...D&dist=hppr Dynamic Alert Limited is pleased to announce that it has appointed Richard Cowan as Director, President and CEO, in the place of Audrey Reich who has resigned. Mr. Cowan has been retained to facilitate the Company entering into the rapidly expanding medical cannabis research and development industry. Cowan's valuable experience, knowledge, and relationships will be instrumental with completing negotiations with…
-
-
- 0 replies
- 947 views
Found this article whilst surfing the net, Its fairly old, but still a interesting read none the less. In particular for people who don't know much about how marijuana affects the body/brain and addiction vs tolerance stuff. http://www.ukcia.org/research/gettman3.htm THE TLDR version for people that can't be bothered clicking the link or reading the entire thing: Cannabis works differently than most other drugs. Most hard drugs, and common drugs etc, ie: Cocaine, Heroin, amphetamines, Alcohol, Tobbaco etc work by adjusting the dopamine levels in your body, which gives you that high/pleasurable feeling, although most often, with extended use, your body naturally re…
Last reply by Wrangler556, -
- 0 replies
- 738 views
ScienceDaily Protecting Brain Cells From Diseases Like Alzheimer's Using New Method ScienceDaily (Aug. 22, 2008)
Last reply by Dragonfan, -
- 0 replies
- 984 views
Researchers explore marijuana and mental health 8 October 2008 physorg.com http://www.physorg.com/news142694179.html A team of mental health experts from the University of Western Sydney say young people who have developed a dependence on cannabis are likely to continue using the drug following the diagnosis of a mental illness. To find out their reasons why, the Social Justice Social Change Research Centre (SJSC) at UWS will commence a study of the links between marijuana and mental health in 2009. Cannabis is one of the most widely used drugs in the world. In Australia, forty to fifty percent of young people admit to trying cannabis at least once. Associate Pr…
Last reply by grace,
